Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 134 (RN7SKP134) is a non-coding RNA sequence annotated as a pseudogene of the functional 7SK small nuclear RNA (snRNA). Pseudogenes like RN7SKP134 are typically remnants of gene duplication or retrotransposition events, and are characterized by their lack of biological function: they do not encode functional RNA or protein products nor participate in cellular processes. In contrast, the functional 7SK snRNA regulates gene expression by controlling RNA polymerase II transcription and is essential for many cellular processes[1][2]. No evidence suggests that RN7SK pseudogene 134 has any physiological, regulatory, or therapeutic relevance. Note: If your interest is in molecular targets relevant to drug action or cellular function, the functional 7SK small nuclear RNA (snRNA)—not its pseudogenes—may be of importance, as it is a regulatory non-coding RNA vital for transcription control and cell homeostasis[1][2]. However, RN7SK pseudogene 134 itself is not such a target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 134 (RN7SKP134).